Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page shows an updated “Revision” version indicator, changing from v3.5.2 to v3.5.3 without affecting the displayed study information.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page displays Revision: v3.4.3, replacing Revision: v3.4.2. No study content or functionality is altered.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 added; notices about government funding lapses and the prior v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedA system notice about a lapse in government funding and NIH operating status was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.